Paper39677882
Infective agents and polymyalgia rheumatica: key discussion points emerging from a narrative review of published literature.
Manzo C and 2 others. Reumatologia, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Infective agents and polymyalgia rheumatica: key discussion points emerging from a narrative review of published literature. Papers, record 39677882. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39677882
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Infective agents and polymyalgia rheumatica: key discussion points emerging from a narrative review of published literature.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References85
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35159168 | Interconnections between Inflammageing and Immunosenescence during Ageing. | Cells | 2022 | https://conductscience.org/library/papers/35159168 | PubMed |
| 2 | 35888074 | Fever Correlation with Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Concentrations in Patients with Isolated Polymyalgia Rheumatica (PMR): A Retrospective Comparison Study between Hospital and Out-of-Hospital Local Registries. | Life (Basel) | 2022 | https://conductscience.org/library/papers/35888074 | PubMed |
| 3 | 9177926 | Antibodies against Chlamydia pneumoniae, cytomegalovirus, enteroviruses and respiratory syncytial virus in patients with polymyalgia rheumatica. | Clin Exp Rheumatol | 1997 | https://conductscience.org/library/papers/9177926 | PubMed |
| 4 | 18830214 | Surveillance for Lyme disease--United States, 1992-2006. | MMWR Surveill Summ | 2008 | https://conductscience.org/library/papers/18830214 | PubMed |
| 5 | 34878092 | Comment on: Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study. | Rheumatology (Oxford) | 2022 | https://conductscience.org/library/papers/34878092 | PubMed |
| 6 | 37328292 | Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group. | RMD Open | 2023 | https://conductscience.org/library/papers/37328292 | PubMed |
| 7 | 34852217 | Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. | Immunity | 2021 | https://conductscience.org/library/papers/34852217 | PubMed |
| 8 | 26527896 | A case of polymyalgia rheumatica following influenza B infection. | Int J Gen Med | 2015 | https://conductscience.org/library/papers/26527896 | PubMed |
| 9 | 31776576 | Assessment for varicella zoster virus in patients newly suspected of having giant cell arteritis. | Rheumatology (Oxford) | 2020 | https://conductscience.org/library/papers/31776576 | PubMed |
| 10 | 31481759 | Rheumatic manifestations of chikungunya: emerging concepts and interventions. | Nat Rev Rheumatol | 2019 | https://conductscience.org/library/papers/31481759 | PubMed |
| 11 | 36321010 | A Case Series on the COVID-19 Vaccines and Possible Immune-Related Adverse Events: A New Challenge for the Rheumatologists. | Cureus | 2022 | https://conductscience.org/library/papers/36321010 | PubMed |
| 12 | 940744 | [Letter: Bacterial endocarditis revealed by rhizomelic pseudopolyarthritis]. | Nouv Presse Med | 1976 | https://conductscience.org/library/papers/940744 | PubMed |
| 13 | 34493606 | Targeted RNA Sequencing of Formalin-Fixed, Paraffin-Embedded Temporal Arteries From Giant Cell Arteritis Cases Reveals Viral Signatures. | Neurol Neuroimmunol Neuroinflamm | 2021 | https://conductscience.org/library/papers/34493606 | PubMed |
| 14 | 34798314 | Immune system activation in polymyalgia rheumatica: Which balance between autoinflammation and autoimmunity? A systematic review. | Autoimmun Rev | 2022 | https://conductscience.org/library/papers/34798314 | PubMed |
| 15 | 30425584 | Does low risk of infections as a marker of effective immunity predict increased risk of subsequent giant cell arteritis or polymyalgia rheumatica? A Danish population-based case-control study. | Clin Epidemiol | 2018 | https://conductscience.org/library/papers/30425584 | PubMed |
| 16 | 28643813 | [Polymyalgia rheumatica: diagnostic and therapeutic issues of an apparently straightforward disease.] | Recenti Prog Med | 2017 | https://conductscience.org/library/papers/28643813 | PubMed |
| 17 | 27481272 | The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. | Rheumatology (Oxford) | 2017 | https://conductscience.org/library/papers/27481272 | PubMed |
| 18 | 37483752 | Incidence of giant cell arteritis is associated with COVID-19 prevalence: A population-level retrospective study. | Heliyon | 2023 | https://conductscience.org/library/papers/37483752 | PubMed |
| 19 | 7816713 | Polymyalgia rheumatica or Lyme disease? How to avoid misdiagnosis in older patients. | Postgrad Med | 1995 | https://conductscience.org/library/papers/7816713 | PubMed |
| 20 | 36963424 | Whipple's Disease - delay of diagnosis by immunosuppressive therapy; a case-series report. | Z Gastroenterol | 2023 | https://conductscience.org/library/papers/36963424 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40508840 | Are There Definite Disease Subsets in Polymyalgia Rheumatica? Suggestions from a Narrative Review. | Healthcare (Basel) | 2025 | https://conductscience.org/library/papers/40508840 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39677882
GET https://conductscience.org/api/papers/v1/39677882/references?page=2